Clinical Research Facility

Ventura, California 93003

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Rheumatoid Arthritis (RA) Clinical Trial
Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Despite MTX Therapy (MK-8457-008 AM6)
Status: Enrolling
Updated: 7/26/2013
mi
from
Ventura, CA
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Ventura, CA
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Ventura, CA
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
mi
from
Ventura, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Efficacy and Safety of BBT-401-1S in Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ventura, CA
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.
Status: Enrolling, Phase III
Updated: 2/9/2016
mi
from
Ventura, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Ventura, CA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
mi
from
Ventura, CA
Click here to add this to my saved trials